Gene · 51393
Papers1,706
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,706
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Ruthenium red: Blocker or antagonist of TRPV channels? | Cell Calcium | 2024 | 38518427 | PubTator, text mining | PubMed |
| Embryonic thermal manipulation reduces hatch time, increases hatchability, thermotolerance, and liver metabolism in broiler embryos. | Poult Sci | 2024 | 38412748 | PubTator, text mining | PubMed |
| Ion channel TRPV2 is critical in enhancing B cell activation and function. | J Exp Med | 2024 | 38353705 | PubTator, text mining | PubMed |
| NY-ESO-1-specific T cell receptor-engineered T cells and Tranilast, a TRPV2 antagonist bivalent treatment enhances the killing of esophageal cancer: a dual-targeted cancer therapeutic route. | Cancer Cell Int | 2024 | 38336680 | PubTator, text mining | PubMed |
| The Putative Role of the Transient Receptor Potential Ion Channel of Vanilloid Type 2 in Red Blood Cell Storage Lesions. | Transfus Med Hemother | 2024 | 38314245 | PubTator, text mining | PubMed |
| Research trends and frontier hotspots of TRPV1 based on bibliometric and visualization analyses. | Heliyon | 2024 | 38293347 | PubTator, text mining | PubMed |
| Experimental and computational biophysics to identify vasodilator drugs targeted at TRPV2 using agonists based on the probenecid scaffold. | Comput Struct Biotechnol J | 2024 | 38261868 | PubTator, text mining | PubMed |
| The Healthy and Diseased Retina Seen through Neuron-Glia Interactions. | Int J Mol Sci | 2024 | 38256192 | PubTator, text mining | PubMed |
| Role of TRP Channels in Metabolism-Related Diseases. | Int J Mol Sci | 2024 | 38255767 | PubTator, text mining | PubMed |
| Matrix stiffness affects tumor-associated macrophage functional polarization and its potential in tumor therapy. | J Transl Med | 2024 | 38246995 | PubTator, text mining | PubMed |
| Epigenetic repression of Cend1 by lysine-specific demethylase 1 is essential for murine heart development. | iScience | 2024 | 38226173 | PubTator, text mining | PubMed |
| Molecular details of ruthenium red pore block in TRPV channels. | EMBO Rep | 2024 | 38225355 | PubTator, text mining | PubMed |
| Selective inhibition of overactive warmth-sensitive Ca2+-permeable TRPV3 channels by antispasmodic agent flopropione for alleviation of skin inflammation. | J Biol Chem | 2024 | 38154600 | PubTator, text mining | PubMed |
| N-acetyl cysteine turns EPAC activators into potent killers of acute lymphoblastic leukemia cells. | J Biol Chem | 2024 | 38042493 | PubTator, text mining | PubMed |
| Targeting Dysregulated Ion Channels in Liver Tumors with Venom Peptides. | Mol Cancer Ther | 2024 | 38015557 | PubTator, text mining | PubMed |
| TRPC5 expression promotes the proliferation and invasion of papillary thyroid carcinoma through the HIF-1α/Twist pathway. | Transl Oncol | 2024 | 37918167 | PubTator, text mining | PubMed |
| High fat diet-induced downregulation of TRPV2 mediates hepatic steatosis via p21 signalling. | J Physiol Biochem | 2024 | 37882938 | PubTator, text mining | PubMed |
| Phosphoinositide Regulation of TRP Channels: A Functional Overview in the Structural Era. | Annu Rev Physiol | 2024 | 37871124 | PubTator, text mining | PubMed |
| Comprehensive modular analyses of scar subtypes illuminate underlying molecular mechanisms and potential therapeutic targets. | Int Wound J | 2024 | 37697692 | PubTator, text mining | PubMed |
| Targeting TRP channels: recent advances in structure, ligand binding, and molecular mechanisms. | Front Mol Neurosci | 2023 | 38273937 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51393/papers?page=6